Transitions of Care for Stroke Patients
NCT06011720
Brain Diseases, Brain Ischemia
New Brunswick, New Jersey, United States
View Trial DetailsNCT Number: NCT06955442
Ischemic stroke is one of the leading causes of mortality and disability worldwide. Although the prevalence of stroke is high globally, not all ethnic and racial groups are affected in the same way, leading to the classification of stroke as an inequitable disease.
First of all, ethnic and racial background influences the pathogenesis of stroke, as numerous risk factors-both modifiable and non-modifiable-are more prevalent in Black and Hispanic populations compared to Asian ones. As a direct consequence, the incidence of stroke is higher in Black and Hispanic individuals than in White individuals. Unfortunately, despite this, access to revascularization treatments is not always guaranteed for ethnic and racial minorities, although in recent years, this inequality in access to care appears to be decreasing.
Moreover, stroke prognosis also seems to differ based on race/ethnicity, with mortality being higher among Black individuals compared to White individuals, although this trend tends to decrease with advancing age. On the other hand, although cerebral hemorrhage is more prevalent in Black and Asian populations than in White populations, it tends to have a better prognosis in these minority groups.
It must be considered, however, that the vast majority of studies on this topic have been conducted in the United States, where the ethnic and racial composition of the population is very different from that of Italy and Europe. In these latter contexts, studies investigating the impact of race and/or ethnicity on the clinical characteristics, management, and prognosis of ischemic stroke are lacking. Furthermore, differences in healthcare system organization may play a significant role in limiting access to timely and appropriate medical care for acute stroke based on race and/or ethnicity.
Italy is a country where, similarly to other European nations, the last few decades have seen a significant increase in immigration rates, particularly from Eastern Europe. Today, foreigners account for approximately 9% of the total population. Nevertheless, in Italy, systemic racism toward ethnic and racial minorities remains a significant issue, as evidenced by large disparities in educational attainment, socioeconomic status, and housing conditions between Italian citizens and foreign residents.
Although the universal national healthcare system in Italy should ensure equal access to care and emergency treatment for all, regardless of ethnic and racial background, there are no studies investigating this topic. A recent scoping review highlighted how individual racism plays a primary role in generating health inequalities, whereas there is very limited evidence focused on the analysis of structural and institutional racism in the Italian and European context.
As a consequence, this study aims to prospectively investigate the presence and the extent of racial and ethnic disparities in access to stroke care and treatment across several Italian comprehensive stroke centers.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Observational
Ospedale Maggiore, IRCCS Istituto delle Scienze Neurologiche di Bologna - UO Neurologia OM e Rete Stroke Metropolitana (SC), Bologna, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline
Comparison of the likelihood of undergoing revascularization treatments among patients from different racial and/or ethnic groups.
Time frame: Baseline
Comparison of Onset-to-Door Time among patients from different racial and/or ethnic groups.
Time frame: From the time of ED admission at baseline to start of intravenous thrombolysis
Comparison of differences in Door-to-Needle Time (DTN) between patients from different racial and/or ethnic groups.
Time frame: From the time of ED admission at baseline to femoral puncture for mechanical thrombectomy
Comparison of differences in Door-to-Groin Time (DTG) between patients from different racial and/or ethnic groups.
Time frame: Baseline
Comparison of ED arrival modes (walk-in vs emergency medical services) among patients from different racial and/or ethnic groups.
Time frame: Baseline
Comparison of the prevalence of cerebrovascular risk factors among patients from different racial and/or ethnic groups.
Time frame: Baseline
Comparison of stroke clinical presentation patterns among patients from different racial and/or ethnic groups.
Time frame: From enrollment to hospital discharge, up to 90-days from baseline
Comparison of stroke etiologies, classified according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria, among patients from different racial and/or ethnic groups.
Time frame: From enrollment to hospital discharge, up to 90-days from baseline
Comparison of discharge modified Rankin Scale (mRS) scores among patients from different racial and/or ethnic groups.
Time frame: From enrollment to the 3-month follow-up visit
Comparison of 3-month modified Rankin Scale (mRS) scores after acute ischemic stroke among patients from different racial and/or ethnic groups.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Other
Analysis of Ethnic and Racial Disparities in Access to Acute Stroke Care in Italy: A Multicentric, Prospective Cohort Study
Acronym: ERDAS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06011720
Brain Diseases, Brain Ischemia
New Brunswick, New Jersey, United States
View Trial DetailsNCT06832579
Arrhythmias, Cardiac, Atrial Fibrillation
Bad Neustadt an der Saale, Germany
View Trial DetailsNCT03812653
Apnea, Brain Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT05991310
Brain Diseases, Cardiovascular Diseases
Melbourne, Victoria, Australia
View Trial Details